Braftovi Interactions
There are 484 drugs known to interact with Braftovi (encorafenib), along with 3 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 159 are major, 322 are moderate, and 3 are minor.
- View all 484 medications that may interact with Braftovi
- View Braftovi alcohol/food interactions (1)
- View Braftovi disease interactions (3)
Most frequently checked interactions
View interaction reports for Braftovi (encorafenib) and the medicines listed below.
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Advate (antihemophilic factor)
- Aldurazyme (laronidase)
- Amicar (aminocaproic acid)
- amoxicillin
- Aubagio (teriflunomide)
- Austedo (deutetrabenazine)
- azithromycin
- Blincyto (blinatumomab)
- Brineura (cerliponase alfa)
- Cerdelga (eliglustat)
- Cesamet (nabilone)
- CoQ10 (ubiquinone)
- Coreg (carvedilol)
- Cosentyx (secukinumab)
- Dupixent (dupilumab)
- Eliquis (apixaban)
- Emgality (galcanezumab)
- enalapril
- Imbruvica (ibrutinib)
- levothyroxine
- Mektovi (binimetinib)
- Pomalyst (pomalidomide)
- Rexulti (brexpiprazole)
- Soliris (eculizumab)
- Stribild (cobicistat / elvitegravir / emtricitabine / tenofovir)
- Valium (diazepam)
- Vitamin D3 (cholecalciferol)
Braftovi alcohol/food interactions
There is 1 alcohol/food interaction with Braftovi (encorafenib).
Braftovi disease interactions
There are 3 disease interactions with Braftovi (encorafenib) which include:
More about Braftovi (encorafenib)
- Braftovi consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.